Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 12/2014

01-12-2014 | Original Article

In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model

Authors: Cajetan Lang, Sebastian Lehner, Andrei Todica, Guido Boening, Mathias Zacherl, Wolfgang-Michael Franz, Bernd Joachim Krause, Peter Bartenstein, Marcus Hacker, Robert David

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2014

Login to get access

Abstract

Purpose

Various strategies have been applied to increase the engraftment of an intramyocardial cell transplant (Tx) to treat ischemic myocardium. Thereby, co-transplanted fibroblasts (FB) improve the long-term survival of stem cell derivatives (SCD) in a murine model of myocardial infarction. For therapeutic use, the time frame in which FB exert putative supportive effects needs to be identified. Therefore, we tracked the biodistribution and retention of SCD and FB in vivo using highly sensitive positron emission tomography (PET) imaging.

Methods

Murine [18 F]-fluorodeoxyglucose (FDG) labeled SCD and FB were transplanted after left anterior descending artery (LAD) ligation into the border zone of the ischemic area in female C57BL/6 mice. Cardiac retention and biodistribution during the initial 2 h after injection were measured via PET imaging.

Results

Massive initial cell loss occurred independently of the cell type. Thereby, FB were retained slightly, yet significantly better than SCD until 60 min post-injection (7.5 ± 1.7 vs. 5.2 ± 0.7 % ID at 25 min and 7.0 ± 1.5 vs. 4.8 ± 0.8 % ID at 60 min). Thereafter, a fraction of ∼5 % that withstood the massive initial washout remained at the site of injection independently of the applied cell type (120 min, SCD vs. FB P = 0.64). Most of the lost cells were detected in the lungs (∼30 % ID).

Conclusions

We were able to quantitatively define the retention and biodistribution of different cell types via PET imaging in a mouse model after intramyocardial Tx. The utmost accuracy was achieved through this cell- and organ-specific approach by correcting PET data for cellular FDG efflux. Thereby, we observed a massive initial cell loss of ∼95 %, causing low rates of long-term engraftment for both SCD and FB. We conclude that FB are not privileged compared to SCD regarding their acute retention kinetics, and therefore exert their beneficial effects at a later time point.
Literature
1.
3.
4.
go back to reference Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, et al. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail. 2012;14(1):91–105. doi:10.1093/eurjhf/hfr148.PubMedCrossRef Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, et al. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail. 2012;14(1):91–105. doi:10.​1093/​eurjhf/​hfr148.PubMedCrossRef
6.
go back to reference Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008;117(9):1189–200. doi:10.1161/CIRCULATIONAHA.107.734103.PubMedCrossRef Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008;117(9):1189–200. doi:10.​1161/​CIRCULATIONAHA.​107.​734103.PubMedCrossRef
7.
go back to reference Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006;203(10):2315–27. doi:10.1084/jem.20061469.PubMedCentralPubMedCrossRef Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006;203(10):2315–27. doi:10.​1084/​jem.​20061469.PubMedCentralPubMedCrossRef
8.
go back to reference Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000;119(6):1169–75.PubMedCrossRef Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000;119(6):1169–75.PubMedCrossRef
11.
go back to reference Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res. 2002;91(10):888–98.PubMedCrossRef Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res. 2002;91(10):888–98.PubMedCrossRef
13.
14.
go back to reference Bonios M, Terrovitis J, Chang CY, Engles JM, Higuchi T, Lautamaki R, et al. Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. J Nucl Cardiol: Off Publ Am Soc Nucl Cardiol. 2011;18(3):443–50. doi:10.1007/s12350-011-9369-9.CrossRef Bonios M, Terrovitis J, Chang CY, Engles JM, Higuchi T, Lautamaki R, et al. Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. J Nucl Cardiol: Off Publ Am Soc Nucl Cardiol. 2011;18(3):443–50. doi:10.​1007/​s12350-011-9369-9.CrossRef
15.
go back to reference Lautamaki R, Terrovitis J, Bonios M, Yu J, Tsui BM, Abraham MR, et al. Perfusion defect size predicts engraftment but not early retention of intra-myocardially injected cardiosphere-derived cells after acute myocardial infarction. Basic Res Cardiol. 2011;106(6):1379–86. doi:10.1007/s00395-011-0197-5.PubMedCentralPubMedCrossRef Lautamaki R, Terrovitis J, Bonios M, Yu J, Tsui BM, Abraham MR, et al. Perfusion defect size predicts engraftment but not early retention of intra-myocardially injected cardiosphere-derived cells after acute myocardial infarction. Basic Res Cardiol. 2011;106(6):1379–86. doi:10.​1007/​s00395-011-0197-5.PubMedCentralPubMedCrossRef
16.
go back to reference Lang C, Lehner S, Todica A, Boening G, Franz WM, Bartenstein P, et al. Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse model. Eur J Nucl Med Mol Imaging. 2013;40(11):1730–8. doi:10.1007/s00259-013-2480-1.PubMedCrossRef Lang C, Lehner S, Todica A, Boening G, Franz WM, Bartenstein P, et al. Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse model. Eur J Nucl Med Mol Imaging. 2013;40(11):1730–8. doi:10.​1007/​s00259-013-2480-1.PubMedCrossRef
17.
go back to reference Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J Off Publ Fed Am Soc Exp Biol. 2000;14(15):2540–8. doi:10.1096/fj.00-0002com. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J Off Publ Fed Am Soc Exp Biol. 2000;14(15):2540–8. doi:10.​1096/​fj.​00-0002com.
18.
go back to reference David R, Brenner C, Stieber J, Schwarz F, Brunner S, Vollmer M, et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol. 2008;10(3):338–45. doi:10.1038/ncb1696.PubMedCrossRef David R, Brenner C, Stieber J, Schwarz F, Brunner S, Vollmer M, et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol. 2008;10(3):338–45. doi:10.​1038/​ncb1696.PubMedCrossRef
20.
go back to reference Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20(7):956–8. doi:10.1096/fj.05-4763fje. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20(7):956–8. doi:10.​1096/​fj.​05-4763fje.
21.
go back to reference van Laake LW, Passier R, Monshouwer-Kloots J, Nederhoff MG, Ward-van Oostwaard D, Field LJ, et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc. 2007;2(10):2551–67. doi:10.1038/nprot.2007.371.PubMedCrossRef van Laake LW, Passier R, Monshouwer-Kloots J, Nederhoff MG, Ward-van Oostwaard D, Field LJ, et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc. 2007;2(10):2551–67. doi:10.​1038/​nprot.​2007.​371.PubMedCrossRef
22.
25.
27.
28.
go back to reference Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F, et al. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 2008;103(11):1327–34. doi:10.1161/CIRCRESAHA.108.180463.PubMedCrossRef Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F, et al. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 2008;103(11):1327–34. doi:10.​1161/​CIRCRESAHA.​108.​180463.PubMedCrossRef
30.
go back to reference Muller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol. 2006;41(5):876–84. doi:10.1016/j.yjmcc.2006.07.023.PubMedCrossRef Muller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol. 2006;41(5):876–84. doi:10.​1016/​j.​yjmcc.​2006.​07.​023.PubMedCrossRef
31.
go back to reference Sakai T, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg. 1999;118(4):715–24.PubMedCrossRef Sakai T, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg. 1999;118(4):715–24.PubMedCrossRef
32.
go back to reference Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 2000;9(3):359–68.PubMed Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 2000;9(3):359–68.PubMed
33.
go back to reference Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation. 2002;105(20):2435–41.PubMedCrossRef Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation. 2002;105(20):2435–41.PubMedCrossRef
34.
36.
go back to reference Kobayashi H, Shimizu T, Yamato M, Tono K, Masuda H, Asahara T, et al. Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs: Off J Jpn Soc Artif Organs. 2008;11(3):141–7. doi:10.1007/s10047-008-0421-8.CrossRef Kobayashi H, Shimizu T, Yamato M, Tono K, Masuda H, Asahara T, et al. Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs: Off J Jpn Soc Artif Organs. 2008;11(3):141–7. doi:10.​1007/​s10047-008-0421-8.CrossRef
37.
go back to reference Mitchell AJ, Sabondjian E, Blackwood KJ, Sykes J, Deans L, Feng Q, et al. Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction. Int J Cardiovasc Imaging. 2013;29(2):497–504. doi:10.1007/s10554-012-0086-5.PubMedCentralPubMedCrossRef Mitchell AJ, Sabondjian E, Blackwood KJ, Sykes J, Deans L, Feng Q, et al. Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction. Int J Cardiovasc Imaging. 2013;29(2):497–504. doi:10.​1007/​s10554-012-0086-5.PubMedCentralPubMedCrossRef
38.
go back to reference Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS. Tissue distribution of 18 F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med: Off Publ Soc Nucl Med. 2006;47(8):1295–301. Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS. Tissue distribution of 18 F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med: Off Publ Soc Nucl Med. 2006;47(8):1295–301.
39.
go back to reference Schots R, De Keulenaer G, Schoors D, Caveliers V, Dujardin M, Verheye S, et al. Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure. Exp Hematol. 2007;35(12):1884–90. doi:10.1016/j.exphem.2007.07.012.PubMedCrossRef Schots R, De Keulenaer G, Schoors D, Caveliers V, Dujardin M, Verheye S, et al. Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure. Exp Hematol. 2007;35(12):1884–90. doi:10.​1016/​j.​exphem.​2007.​07.​012.PubMedCrossRef
40.
go back to reference Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169(1):12–20.PubMedCrossRef Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169(1):12–20.PubMedCrossRef
41.
go back to reference Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis (N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A. 2002;99(5):3030–5. doi:10.1073/pnas.052709599.PubMedCentralPubMedCrossRef Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis (N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A. 2002;99(5):3030–5. doi:10.​1073/​pnas.​052709599.PubMedCentralPubMedCrossRef
42.
go back to reference Botti C, Negri DR, Seregni E, Ramakrishna V, Arienti F, Maffioli L, et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med. 1997;24(5):497–504.PubMed Botti C, Negri DR, Seregni E, Ramakrishna V, Arienti F, Maffioli L, et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med. 1997;24(5):497–504.PubMed
43.
go back to reference Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18 F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med: Off Publ, Soc Nucl Med. 1978;19(10):1154–61. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18 F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med: Off Publ, Soc Nucl Med. 1978;19(10):1154–61.
44.
45.
go back to reference Stojanov K, de Vries EF, Hoekstra D, van Waarde A, Dierckx RA, Zuhorn IS. [18 F] FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin. Mol Imaging. 2012;11(1):1–12.PubMed Stojanov K, de Vries EF, Hoekstra D, van Waarde A, Dierckx RA, Zuhorn IS. [18 F] FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin. Mol Imaging. 2012;11(1):1–12.PubMed
47.
go back to reference Wolfs E, Struys T, Notelaers T, Roberts SJ, Sohni A, Bormans G, et al. 18 F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med: Off Publ, Soc Nucl Med. 2013;54(3):447–54. doi:10.2967/jnumed.112.108316.CrossRef Wolfs E, Struys T, Notelaers T, Roberts SJ, Sohni A, Bormans G, et al. 18 F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med: Off Publ, Soc Nucl Med. 2013;54(3):447–54. doi:10.​2967/​jnumed.​112.​108316.CrossRef
Metadata
Title
In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model
Authors
Cajetan Lang
Sebastian Lehner
Andrei Todica
Guido Boening
Mathias Zacherl
Wolfgang-Michael Franz
Bernd Joachim Krause
Peter Bartenstein
Marcus Hacker
Robert David
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-014-2858-8

Other articles of this Issue 12/2014

European Journal of Nuclear Medicine and Molecular Imaging 12/2014 Go to the issue